Stocks and Investing Stocks and Investing
Fri, November 3, 2017

Matthew Harrison Upgraded (BLUE) to Hold on, Nov 3rd, 2017


Published on 2024-10-26 00:31:26 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Upgraded "bluebird bio, Inc." (BLUE) to Hold on, Nov 3rd, 2017.

Matthew has made no other calls on BLUE in the last 4 months.



There are 6 other peers that have a rating on BLUE. Out of the 6 peers that are also analyzing BLUE, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Biren Amin of "Jefferies" Downgraded from Strong Buy to Hold on, Wednesday, October 11th, 2017
  • Vincent Chen of "Bernstein" Initiated at Hold and Held Target at $109 on, Thursday, July 27th, 2017


These are the ratings of the 4 analyists that currently disagree with Matthew


  • Dane Leone of "BTIG" Upgraded from Hold to Strong Buy on, Thursday, November 2nd, 2017
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $162 on, Thursday, November 2nd, 2017
  • Matthew Luchini of "BMO Capital" Maintained at Buy with Increased Target to $162 on, Monday, October 30th, 2017
  • Josh Schimmer of "Evercore ISI Group" Upgraded from Hold to Buy on, Monday, October 16th, 2017
Contributing Sources